Health
Neanderthal-derived protein may reduce the severity of COVID-19 – Medical Xpress
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced…
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes. The findings are published today in Nature Medicine.
“Our analysis shows evidence that OAS1 has a protective effect against COVID-19 susceptibility and severity,” explains…
-
General19 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business18 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General23 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General22 hours agoMandatory sentencing reinstated for some DVO breaches in NT after bill passes parliament